Headquartered in Seoul, South Korea, Microgentas focuses on integrated exosome isolation and miRNA extraction.
The company provides solutions to sample preparation challenges with its core technologies, offering faster, cost-effective, scalable, user-friendly exosome isolation kits: ExoCASโข, ExoPASโข, ExoFilterโข, and exosomal microRNA extraction kits, miRQuickโข.
Microgentas is also developing EV research related to exosome-based biomarkers for diagnosing and monitoring breast cancer, collaborating with Korea University Anam Hospital.
Also collaborating with cosmetic companies who is willing to use exosome as their ingredients.